ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

NIH director would have broad authority over institute budgets in proposed bill.

July 22, 2005

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004